A different one CCP virus there are properties that can help it be more resistant to current vaccines or to the resistance a person has acquired from the past COVID-19 infection, according to a new study reviewed by colleagues.
The unique “Epsilon”, first found in California in May 2020, there were three modifications to the spike protein that would help it neutralize antibodies produced by mRNA vaccines such as Pfizer and Moderna, researchers from the University of Washington and lab of San Francisco -based Bi Francisco in their report. .
Spike proteins are found on the surface of the coronavirus and this is what enables the virus to attach to and enter human cells. Anti -vaccines are currently being used.
The study, published in the journal Science on July 1, suggests that modification of the spike protein may also help the Epsilon variant avoid the resistance a person has developed in the past from previous CCP virus infection, which causes COVID-19 disease.
The efficacy of antibodies produced with current vaccines or with previous infection in a person is 50 to 70 percent less effective against the Epsilon variety than against the wild-class circulating diseases of CCP. virus (with no stem mutation), consistent with the study findings. – READ MORE
Listen to the insightful Thomas Paine Podcast Below –